GEL SOLAIRE BRONZAGE INTENSIF SPF 3 - 3.15% 3.15 %
2-PHENYLBENZIMIDAZOLE-5-SULFONIC ACID TEA SLT : 3.15 % · DIN 02165244 · LABORATOIRES CLARINS
Health Canada status: CANCELLED POST MARKET
What is GEL SOLAIRE BRONZAGE INTENSIF SPF 3 - 3.15%?
GEL SOLAIRE BRONZAGE INTENSIF SPF 3 - 3.15% 3.15 % contains 2-PHENYLBENZIMIDAZOLE-5-SULFONIC ACID TEA SLT : 3.15 %. It is listed in the Health Canada Drug Product Database under DIN 02165244, held by LABORATOIRES CLARINS, supplied as GEL for TOPICAL administration. Health Canada currently lists it as cancelled post market, status dated 23-Jul-1998. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02165244 |
|---|---|
| Brand name | GEL SOLAIRE BRONZAGE INTENSIF SPF 3 - 3.15% |
| Generic / active ingredient | 2-PHENYLBENZIMIDAZOLE-5-SULFONIC ACID TEA SLT : 3.15 % |
| Manufacturer | LABORATOIRES CLARINS |
| Strength | 3.15 % |
| Dosage form | GEL |
| Route of administration | TOPICAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | D02BA PROTECTIVES AGAINST UV-RADIATION FOR TOPICAL USE |
| AHFS class | 38:00.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 23-Jul-1998 |
| Original market date | 1996-08-30 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code D02BA PROTECTIVES AGAINST UV-RADIATION FOR TOPICAL USE. 1 of 197 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| WATER DRENCH | 3 % | LOTION | PETER THOMAS ROTH LABS LLC | MARKETED | DIN 02506971 |
| A M HAND CREAM SPF 15 | 5 % | CREAM | LA PRAIRIE INC. | CANCELLED POST MARKET | DIN 02241020 |
| A M INTENSIFIED EMULSION SPF 8 | 2.4 % | LOTION | LA PRAIRIE INC. | CANCELLED POST MARKET | DIN 02241335 |
| ADAPTIVE FPS 10 | 1.8 % | CREAM | LANCOME CANADA | CANCELLED POST MARKET | DIN 02246004 |
| ALMAY AMAZING LASTING 16 HOUR CONCEALER SPF 6 (SHADES LIGHT AND MEDIUM) | 8.8 % | STICK | REVLON CANADA INC | CANCELLED POST MARKET | DIN 02246037 |
| ALMAY KINETIN SKIN-SMOOTHING CONCEALER SPF 10 | 8.9 % | LIQUID | REVLON CANADA INC | CANCELLED POST MARKET | DIN 02245216 |
| ALMOST MAKEUP SPF 15 - DEEP - CREAM 6.4% | 6.4 % | CREAM | CLINIQUE LABORATORIES DIST | CANCELLED POST MARKET | DIN 02160862 |
| ALMOST MAKEUP SPF 15 - FAIR - CREAM 8.0% | 8 % | CREAM | CLINIQUE LABORATORIES DIST | CANCELLED POST MARKET | DIN 02161516 |
| ALMOST MAKEUP SPF 15 - LIGHT - CREAM 7.3% | 7.3 % | CREAM | CLINIQUE LABORATORIES DIST | CANCELLED POST MARKET | DIN 02160846 |
| ALMOST MAKEUP SPF 15 - MEDIUM - CREAM 7.6% | 7.6 % | CREAM | CLINIQUE LABORATORIES DIST | CANCELLED POST MARKET | DIN 02160854 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.